Distinguished in Primitive Neuroectodermal Tumor (PNET)

Dr. Tracy T. Batchelor

Neurology
Brigham And Womens Physicians Organization Inc
75 Francis St, 
Boston, MA 
Accepting New Patients
Offers Telehealth
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Brigham And Womens Physicians Organization Inc
75 Francis St, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Tracy Batchelor is a Neurologist in Boston, Massachusetts. Dr. Batchelor is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Gliomatosis Cerebri, and Tissue Biopsy. Dr. Batchelor is currently accepting new patients.

His clinical research consists of co-authoring 247 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in MA
Hospital Affiliations
Brigham And Women's Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

BRIGHAM AND WOMENS PHYSICIANS ORGANIZATION INC
75 Francis St, Boston, MA 02115

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
Enrollment Status: Active_not_recruiting
Publish Date: February 26, 2024
Intervention Type: Biological
Study Drug: SurVaxM
Study Phase: Phase 2
A Phase Ib/II Study of AZD2171 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma Not Taking Enzyme-Inducing Anti-epileptic Drugs
A Phase Ib/II Study of AZD2171 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma Not Taking Enzyme-Inducing Anti-epileptic Drugs
Enrollment Status: Completed
Publish Date: June 06, 2023
Intervention Type: Procedure, Other, Radiation, Drug
Study Phase: Phase 1/Phase 2
Randomized, Phase II, Double-Blind, Placebo-Controlled Trial of Conventional Chemoradiation and Adjuvant Temozolomide Plus Cediranib Versus Conventional Chemoradiation and Adjuvant Temozolomide Plus Placebo in Patients With Newly Diagnosed Glioblastoma
Randomized, Phase II, Double-Blind, Placebo-Controlled Trial of Conventional Chemoradiation and Adjuvant Temozolomide Plus Cediranib Versus Conventional Chemoradiation and Adjuvant Temozolomide Plus Placebo in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Other, Radiation, Drug
Study Drugs: Cediranib, Temozolomide
Study Phase: Phase 2
A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma
A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2021
Intervention Type: Drug, Procedure
Study Drugs: Carmustine, Cytarabine, Etoposide, Thiotepa, Granulocyte Colony-Stimulating Factor
Study Phase: Phase 2
A Study to Evaluate Vascular Normalization in Patients With Recurrent Glioblastoma Treated With Bevacizumab Using FMISO PET and Vascular MRI
A Study to Evaluate Vascular Normalization in Patients With Recurrent Glioblastoma Treated With Bevacizumab Using FMISO PET and Vascular MRI
Enrollment Status: Completed
Publish Date: July 30, 2021
Intervention Type: Device, Drug
Study Phase: Not Applicable
A Study to Evaluate Vascular Normalization in Patients With Recurrent Glioblastoma Treated With Bevacizumab Using [11C]Temozolomide PET and Vascular MRI
A Study to Evaluate Vascular Normalization in Patients With Recurrent Glioblastoma Treated With Bevacizumab Using [11C]Temozolomide PET and Vascular MRI
Enrollment Status: Completed
Publish Date: September 04, 2020
Intervention Type: Device
Study Phase: Not Applicable
A Feasibility Assessment and a Phase I/II Trial of MLN518 for Treatment of Patients With Recurrent Glioblastoma
A Feasibility Assessment and a Phase I/II Trial of MLN518 for Treatment of Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: April 07, 2017
Intervention Type: Drug, Other, Procedure
Study Phase: Phase 1/Phase 2
View 6 Less Clinical Trials

247 Total Publications

A pilot study to quantify and describe personal social networks in patients with glioblastoma.
A pilot study to quantify and describe personal social networks in patients with glioblastoma.
Journal: Neuro-oncology practice
Published: June 09, 2025
Similar Doctors
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Patrick Y. Wen
Neurology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Patrick Y. Wen
Neurology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (0.1 miles away)
617-632-3586
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Patrick Wen is a Neurologist in Boston, Massachusetts. Dr. Wen is rated as an Elite provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Wen is currently accepting new patients.

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Erik Uhlmann
Neurology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Erik Uhlmann
Neurology

Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc

330 Brookline Ave, 
Boston, MA 
 (0.3 miles away)
617-754-8612
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Erik Uhlmann is a Neurologist in Boston, Massachusetts. Dr. Uhlmann is rated as an Elite provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Metastatic Brain Tumor, Brain Tumor, Astrocytoma, Glioblastoma, and Gamma Knife Radiosurgery.

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Eudocia Q. Lee
Neurology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Eudocia Q. Lee
Neurology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Eudocia Lee is a Neurologist in Boston, Massachusetts. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Astrocytoma, Gliosarcoma, Glioblastoma, and Embryonal Tumor with Multilayered Rosettes. Dr. Lee is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Batchelor's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 12 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile